These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 1750446

  • 21. Defining the spectrum of immunoglobulin A-dominant/codominant glomerular deposition in diabetic nephropathy.
    Cossey LN, Messias N, Messias E, Walker PD, Silva FG.
    Hum Pathol; 2014 Nov; 45(11):2294-301. PubMed ID: 25239033
    [Abstract] [Full Text] [Related]

  • 22. Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis.
    Schulze M, Pruchno CJ, Burns M, Baker PJ, Johnson RJ, Couser WG.
    Am J Pathol; 1993 Jan; 142(1):179-87. PubMed ID: 7678717
    [Abstract] [Full Text] [Related]

  • 23. Immunofluorescent studies on IgA nephropathy: type IV collagen and glomerular basement membrane component detected by Goodpasture's syndrome serum and laminin.
    Tomino Y, Nomoto Y, Sakai H.
    Tokai J Exp Clin Med; 1988 Aug; 13(3):137-43. PubMed ID: 3075823
    [Abstract] [Full Text] [Related]

  • 24. IgG deposits in the mesangium and capillary loops predict poor renal outcome in patients with IgA nephropathy: a single-center retrospective study.
    Peng S, Lu W, Jiang X, Xu X, Wu Y.
    Ren Fail; 2020 Nov; 42(1):902-911. PubMed ID: 32869693
    [Abstract] [Full Text] [Related]

  • 25. Determination of tissue type plasminogen activator in the glomeruli of patients with IgA nephropathy.
    Garcia G, Miura M, Nomoto Y, Sakai H.
    Tokai J Exp Clin Med; 1989 Apr; 14(2):131-7. PubMed ID: 2517871
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Hepatic glomerulosclerosis with IgA deposition. Report of three cases.
    Suga T, Endoh M, Miura M, Tomino Y, Nomoto Y, Sakai H.
    Tokai J Exp Clin Med; 1983 Nov; 8(4):317-24. PubMed ID: 6388033
    [Abstract] [Full Text] [Related]

  • 28. Coexistence of IgA nephropathy and membranous nephropathy.
    Kobayashi Y, Fujii K, Hiki Y, Chen XM.
    Acta Pathol Jpn; 1985 Sep; 35(5):1293-9. PubMed ID: 3909735
    [Abstract] [Full Text] [Related]

  • 29. IgA deposits might not influence the production of extracellular matrix in glomeruli of ddY mice, a spontaneous animal model for IgA nephropathy.
    Tsushima Y, Tomino Y, Shimizu M, Ohmuro H, Takeuchi K, Kuramoto T, Shirato I, Koide H.
    Nephron; 1994 Sep; 66(1):81-6. PubMed ID: 7906404
    [Abstract] [Full Text] [Related]

  • 30. [Clinico-pathological characteristics and prognosis of IgA nephropathy patients with microalbuminuria and deposition of complement C3].
    Guo ZY, Zhou SG, Wang YY, Li X, Xu Y, Du XY, Zhang W, Wu YM.
    Zhonghua Yi Xue Za Zhi; 2016 Mar 08; 96(9):707-11. PubMed ID: 27055509
    [Abstract] [Full Text] [Related]

  • 31. Effect of immunoglobulin depositions of glomerular sialic acids in patients with IgA nephropathy.
    Tomino Y, Sakai H, Miura M, Suga T, Yagame M, Endoh M, Nomoto Y.
    Am J Nephrol; 1986 Mar 08; 6(3):187-92. PubMed ID: 3526892
    [Abstract] [Full Text] [Related]

  • 32. Antigen as mediator of glomerular injury in experimental IgA nephropathy.
    Montinaro V, Esparza AR, Cavallo T, Rifai A.
    Lab Invest; 1991 Apr 08; 64(4):508-19. PubMed ID: 2016857
    [Abstract] [Full Text] [Related]

  • 33. Glomerulopathy with IgA deposition in the dog.
    Miyauchi Y, Nakayama H, Uchida K, Uetsuka K, Hasegawa A, Goto N.
    J Vet Med Sci; 1992 Oct 08; 54(5):969-75. PubMed ID: 1420580
    [Abstract] [Full Text] [Related]

  • 34. Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schönlein nephritis: association between CD71 expression and IgA deposits.
    Haddad E, Moura IC, Arcos-Fajardo M, Macher MA, Baudouin V, Alberti C, Loirat C, Monteiro RC, Peuchmaur M.
    J Am Soc Nephrol; 2003 Feb 08; 14(2):327-37. PubMed ID: 12538733
    [Abstract] [Full Text] [Related]

  • 35. Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy.
    Gesualdo L, Ricanati S, Hassan MO, Emancipator SN, Lamm ME.
    J Clin Invest; 1990 Sep 08; 86(3):715-22. PubMed ID: 2203821
    [Abstract] [Full Text] [Related]

  • 36. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis.
    Hisano S, Matsushita M, Fujita T, Endo Y, Takebayashi S.
    Am J Kidney Dis; 2001 Nov 08; 38(5):1082-8. PubMed ID: 11684563
    [Abstract] [Full Text] [Related]

  • 37. Role of differential and cell type-specific expression of cell cycle regulatory proteins in mediating progressive glomerular injury in human IgA nephropathy.
    Qiu LQ, Sinniah R, Hsu SI.
    Lab Invest; 2004 Sep 08; 84(9):1112-25. PubMed ID: 15208647
    [Abstract] [Full Text] [Related]

  • 38. IgA nephropathy in children: significance of glomerular basement membrane deposition of IgA.
    Andreoli SP, Yum MN, Bergstein JM.
    Am J Nephrol; 1986 Sep 08; 6(1):28-33. PubMed ID: 3515942
    [Abstract] [Full Text] [Related]

  • 39. The number of CD10-positive glomerular epithelial cells reflects renal prognosis in IgA nephropathy patients.
    Sasaoka A, Nishiya K, Hosokawa T, Ito H, Hashimoto K, Enzan H.
    Clin Nephrol; 2003 Nov 08; 60(5):305-14. PubMed ID: 14640235
    [Abstract] [Full Text] [Related]

  • 40. The tetraspanin CD37 protects against glomerular IgA deposition and renal pathology.
    Rops AL, Figdor CG, van der Schaaf A, Tamboer WP, Bakker MA, Berden JH, Dijkman HB, Steenbergen EJ, van der Vlag J, van Spriel AB.
    Am J Pathol; 2010 May 08; 176(5):2188-97. PubMed ID: 20348240
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.